E-LIB Suche - Ergebnisse für: Klamroth, Robert

1

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andre...
Reding, Mark T. Pabinger, Ingrid Holme, Pål Andre Maas Enriquez, Monika Mancuso, Maria Elisa Lalezari, Shadan Miesbach, Wolfgang Di Minno, Giovanni Klamroth, Robert Hermans, Cedric . Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study. Therapeutic Advances in Hematology (TAH). 2023, 14. , 2023

Link: http://hdl.handle.net/10..

2

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia :

Pipe, Steven W ; Leebeek, Frank W.G ; Recht, Michael...
https://research.rug.nl/en/publications/bcd8e7fb-66c2-4b0f-b235-d2995c4d444f. , 2023

Link: https://hdl.handle.net/1..

3

Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients wit..:

Mancuso, Maria Elisa ; Eriksson, Daniel ; Falk, Aletta...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JBM.S389094. , 2023

Link: https://www.dovepress.co..

4

Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients wit..:

Mancuso, Maria Elisa ; Eriksson, Daniel ; Falk, Aletta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390690/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Gentherapie der Hämophilie: Empfehlung der Gesellschaft für..:

Miesbach, Wolfgang ; Oldenburg, Johannes ; Klamroth, Robert...
https://boris.unibe.ch/176932/. , 2023

Link: https://boris.unibe.ch/1..

6

P1633: OUTCOME OF SURGICAL INTERVENTIONS IN PATIENTS WITH H..:

Vaide, Ines ; Gottstein, Saskia ; Kubicek, Cornelia..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430121/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andrè...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126693/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hem..:

von Drygalski, Annette ; Chowdary, Pratima ; Kulkarni, Roshni...
info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa2209226. , 2023

Link: https://hal.science/hal-..

9

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hem..:

von Drygalski, Annette ; Chowdary, Pratima ; Kulkarni, Roshni...
info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa2209226. , 2023

Link: https://hal.science/hal-..

10

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andrè...
boreal:275609. , 2023

Link: http://hdl.handle.net/20..

11

Antithrombotic Treatment in Patients With Hemophilia: an EH..:

Schutgens, Roger EG ; Jimenez-Yuste, Victor ; Escobar, Miguel...
https://discovery.ucl.ac.uk/id/eprint/10172590/1/Antithrombotic_Treatment_in_Patients_With.18.pdf. , 2023

Link: https://discovery.ucl.ac..

12

Fitusiran prophylaxis in people with severe haemophilia A o..:

Srivastava, Alok ; Rangarajan, Savita ; Kavakli, Kaan...
https://eprints.soton.ac.uk/477603/1/Fitusiran_003_ATLAS_INH_revised_4.0_tracked.docx. , 2023

Link: https://eprints.soton.ac..

13

Targeting an elevated FVIII level using personalized rurioc..:

Escuriola-Ettingshausen, Carmen ; Klamroth, Robert ; Escobar, Miguel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350756/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Antithrombotic Treatment in Patients With Hemophilia : an E..:

Schutgens, Roger E. G ; Jimenez-Yuste, Victor ; Escobar, Miguel...
10.1097/HS9.0000000000000900. , 2023

Link: http://hdl.handle.net/10..

15

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andrè...
boreal:275609. , 2023

Link: http://hdl.handle.net/20..